Craig Ballaron's most recent trade in Verrica Pharmaceuticals Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc | Craig Ballaron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Verrica Pharmaceuticals Inc | Craig Ballaron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 10,384 | 10,384 | - | - | Stock Option (right to buy) | |
| Verrica Pharmaceuticals Inc | Craig Ballaron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 10,384 | 10,384 | - | - | Stock Option (right to buy) | |
| Verrica Pharmaceuticals Inc | Craig Ballaron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 8,109 | 8,109 | - | - | Stock Option (right to buy) | |
| Verrica Pharmaceuticals Inc | Craig Ballaron | Director | Purchase of securities on an exchange or from another person at price $ 9.16 per share. | 24 Aug 2020 | 5,228 | 5,228 (0%) | 0% | 9.2 | 47,888 | Common Stock |
| Verrica Pharmaceuticals Inc | Craig Ballaron | Director | Purchase of securities on an exchange or from another person at price $ 8.57 per share. | 24 Aug 2020 | 4,772 | 10,000 (0%) | 0% | 8.6 | 40,896 | Common Stock |